"Advances and emerging trends in in-cell NMR: From structural biology to drug discovery" by Masanari Tsujimura, Misaki Imai, Yuki Toyama, Yutaka Kofuku, Koh Takeuchi is published in BPPB as the J-STAGE Advance Publication.
2026 November 18 BPPB
A following article is published as the J-STAGE Advance Publication in "Biophysics and Physicobiology".
Masanari Tsujimura, Misaki Imai, Yuki Toyama, Yutaka Kofuku, Koh Takeuchi
"Advances and emerging trends in in-cell NMR: From structural biology to drug discovery"
URL:https://doi.org/10.2142/biophysico.bppb-v24.s003

Large Image
- Abstract
- While structural biology has traditionally relied on in vitro approaches, the crowded intracellular environment can alter the structural, thermodynamic, and functional properties of biomacromolecules. NMR spectroscopy has the unique capability of non-invasively characterizing biomolecular dynamics, conformational equilibria, and interactions directly at near-atomic resolution even within living cells. This review highlights recent advancements in in-cell NMR methodologies, including continuous-perfusion bioreactor systems, various detection strategies, and experimental techniques. We emphasize the potential of in-cell NMR techniques for establishing an integrated “in-cell drug discovery”, which addresses the methodological disconnect between in vitro activity and in vivo efficacy. Specifically, we describe the development of a gel-free floating bioreactor system that enables the quantification of cell permeability and intracellular target binding affinity for hydrophobic middle-sized molecules. Finally, we discuss how evaluating dynamic structural equilibria under intracellular conditions will become indispensable for understanding biological phenomena and optimizing next-generation therapeutics, such as proteolysis-targeting chimeras (PROTACs).